Annual Total Debt
$1.75 B
+$941.10 M+116.42%
December 31, 2024
Summary
- As of February 24, 2025, VRTX annual total debt is $1.75 billion, with the most recent change of +$941.10 million (+116.42%) on December 31, 2024.
- During the last 3 years, VRTX annual total debt has risen by +$782.10 million (+80.85%).
- VRTX annual total debt is now at all-time high.
Performance
VRTX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$1.75 B
+$46.60 M+2.74%
December 31, 2024
Summary
- As of February 24, 2025, VRTX quarterly total debt is $1.75 billion, with the most recent change of +$46.60 million (+2.74%) on December 31, 2024.
- Over the past year, VRTX quarterly total debt has increased by +$941.10 million (+116.42%).
- VRTX quarterly total debt is now at all-time high.
Performance
VRTX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
VRTX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +116.4% | +116.4% |
| 3 y3 years | +80.8% | +112.2% |
| 5 y5 years | +164.4% | +112.2% |
VRTX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +116.4% | at high | +142.6% |
| 5 y | 5-year | at high | +164.4% | at high | +235.1% |
| alltime | all time | at high | >+9999.0% | at high | -100.0% |
Vertex Pharmaceuticals Incorporated Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.75 B(+116.4%) | $1.75 B(+2.7%) |
| Sep 2024 | - | $1.70 B(+82.4%) |
| Jun 2024 | - | $933.40 M(+29.4%) |
| Mar 2024 | - | $721.30 M(-10.8%) |
| Dec 2023 | $808.40 M(-10.1%) | $808.40 M(+8.6%) |
| Sep 2023 | - | $744.70 M(-3.0%) |
| Jun 2023 | - | $767.60 M(-2.7%) |
| Mar 2023 | - | $789.20 M(-12.3%) |
| Dec 2022 | $899.70 M(-7.0%) | $899.70 M(+9.1%) |
| Sep 2022 | - | $824.60 M(-2.7%) |
| Jun 2022 | - | $847.30 M(-2.9%) |
| Mar 2022 | - | $872.50 M(-9.8%) |
| Dec 2021 | $967.40 M(+3.8%) | $967.40 M(+10.3%) |
| Sep 2021 | - | $876.80 M(-1.9%) |
| Jun 2021 | - | $893.85 M(-0.6%) |
| Mar 2021 | - | $898.80 M(-3.6%) |
| Dec 2020 | $931.90 M(+40.8%) | $931.90 M(+70.5%) |
| Sep 2020 | - | $546.51 M(+4.7%) |
| Jun 2020 | - | $522.07 M(-2.0%) |
| Mar 2020 | - | $532.95 M(-19.5%) |
| Dec 2019 | $661.66 M(+12.8%) | $661.66 M(+9.4%) |
| Sep 2019 | - | $604.54 M(-1.2%) |
| Jun 2019 | - | $611.96 M(-1.9%) |
| Mar 2019 | - | $623.87 M(+6.3%) |
| Dec 2018 | $586.82 M(-3.2%) | $586.82 M(-0.2%) |
| Sep 2018 | - | $588.04 M(-0.8%) |
| Jun 2018 | - | $592.74 M(-0.4%) |
| Mar 2018 | - | $595.13 M(-1.9%) |
| Dec 2017 | $606.43 M(-27.9%) | $606.43 M(+3.3%) |
| Sep 2017 | - | $587.19 M(+3.3%) |
| Jun 2017 | - | $568.54 M(+3.7%) |
| Mar 2017 | - | $548.40 M(-34.8%) |
| Dec 2016 | $840.76 M(+1.8%) | $840.76 M(+2.5%) |
| Sep 2016 | - | $820.32 M(-0.0%) |
| Jun 2016 | - | $820.63 M(-0.5%) |
| Mar 2016 | - | $824.49 M(-0.2%) |
| Dec 2015 | $826.24 M(+0.2%) | $826.24 M(+0.6%) |
| Sep 2015 | - | $820.98 M(-0.4%) |
| Jun 2015 | - | $824.47 M(-1.1%) |
| Mar 2015 | - | $833.91 M(+1.1%) |
| Dec 2014 | $824.95 M(+62.8%) | $824.95 M(-0.4%) |
| Sep 2014 | - | $828.24 M(+53.9%) |
| Jun 2014 | - | $538.03 M(-0.6%) |
| Mar 2014 | - | $541.18 M(+6.8%) |
| Dec 2013 | $506.58 M(-27.3%) | $506.58 M(+13.5%) |
| Sep 2013 | - | $446.38 M(+12.2%) |
| Jun 2013 | - | $397.85 M(-46.2%) |
| Mar 2013 | - | $739.88 M(+6.2%) |
| Dec 2012 | $696.91 M(+52.8%) | $696.91 M(+74.2%) |
| Sep 2012 | - | $400.00 M(0.0%) |
| Jun 2012 | - | $400.00 M(0.0%) |
| Mar 2012 | - | $400.00 M(-12.3%) |
| Dec 2011 | $455.95 M(-15.1%) | $455.95 M(-8.5%) |
| Sep 2011 | - | $498.42 M(+0.8%) |
| Jun 2011 | - | $494.66 M(+0.5%) |
| Mar 2011 | - | $492.10 M(-8.4%) |
| Dec 2010 | $536.99 M(+249.1%) | $536.99 M(+10.2%) |
| Sep 2010 | - | $487.23 M(+463.9%) |
| Jun 2010 | - | $86.41 M(-31.0%) |
| Mar 2010 | - | $125.32 M(-18.5%) |
| Dec 2009 | $153.84 M(-46.5%) | $153.84 M(-41.5%) |
| Sep 2009 | - | $262.84 M(+82.5%) |
| Jun 2009 | - | $144.00 M(-49.9%) |
| Mar 2009 | - | $287.50 M(0.0%) |
| Dec 2008 | $287.50 M(+1337.7%) | $287.50 M(0.0%) |
| Sep 2008 | - | $287.50 M(0.0%) |
| Jun 2008 | - | $287.50 M(0.0%) |
| Mar 2008 | - | $287.50 M(+1337.7%) |
| Dec 2007 | $20.00 M | $20.00 M(0.0%) |
| Sep 2007 | - | $20.00 M(-67.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2007 | - | $62.10 M(-4.8%) |
| Mar 2007 | - | $65.23 M(-47.3%) |
| Dec 2006 | $123.75 M(-31.3%) | $123.75 M(+21.6%) |
| Sep 2006 | - | $101.75 M(-43.5%) |
| Jun 2006 | - | $180.09 M(-0.0%) |
| Mar 2006 | - | $180.10 M(0.0%) |
| Dec 2005 | $180.10 M(-46.2%) | $180.10 M(-38.9%) |
| Sep 2005 | - | $294.55 M(-12.1%) |
| Jun 2005 | - | $335.00 M(0.0%) |
| Mar 2005 | - | $335.00 M(0.0%) |
| Dec 2004 | $335.00 M(+0.5%) | $335.00 M(+4.8%) |
| Sep 2004 | - | $319.69 M(-0.9%) |
| Jun 2004 | - | $322.61 M(+2.4%) |
| Mar 2004 | - | $315.04 M(-5.5%) |
| Dec 2003 | $333.46 M(+1.6%) | $333.46 M(-3.4%) |
| Sep 2003 | - | $345.33 M(+1.3%) |
| Jun 2003 | - | $340.78 M(+3.3%) |
| Mar 2003 | - | $329.90 M(+0.5%) |
| Dec 2002 | $328.14 M(+0.2%) | $328.14 M(+1.2%) |
| Sep 2002 | - | $324.28 M(-0.3%) |
| Jun 2002 | - | $325.25 M(-0.3%) |
| Mar 2002 | - | $326.26 M(-0.4%) |
| Dec 2001 | $327.61 M(-9.6%) | $327.61 M(-8.7%) |
| Sep 2001 | - | $358.75 M(+2.9%) |
| Jun 2001 | - | $348.65 M(-0.1%) |
| Mar 2001 | - | $349.15 M(-3.6%) |
| Dec 2000 | $362.34 M(+5033.0%) | $362.34 M(-29.2%) |
| Sep 2000 | - | $511.92 M(+183.1%) |
| Jun 2000 | - | $180.82 M(-0.3%) |
| Mar 2000 | - | $181.43 M(+2470.2%) |
| Dec 1999 | $7.06 M(-28.0%) | $7.06 M(-9.5%) |
| Sep 1999 | - | $7.80 M(-7.1%) |
| Jun 1999 | - | $8.40 M(-7.7%) |
| Mar 1999 | - | $9.10 M(-7.1%) |
| Dec 1998 | $9.80 M(+16.7%) | $9.80 M(-5.8%) |
| Sep 1998 | - | $10.40 M(+8.3%) |
| Jun 1998 | - | $9.60 M(+10.3%) |
| Mar 1998 | - | $8.70 M(+3.6%) |
| Dec 1997 | $8.40 M(-1.2%) | $8.40 M(+2.4%) |
| Sep 1997 | - | $8.20 M(0.0%) |
| Jun 1997 | - | $8.20 M(+1.2%) |
| Mar 1997 | - | $8.10 M(-4.7%) |
| Dec 1996 | $8.50 M(+21.4%) | $8.50 M(+23.2%) |
| Sep 1996 | - | $6.90 M(0.0%) |
| Jun 1996 | - | $6.90 M(+6.2%) |
| Mar 1996 | - | $6.50 M(-7.1%) |
| Dec 1995 | $7.00 M(+9.4%) | $7.00 M(+2.9%) |
| Sep 1995 | - | $6.80 M(-1.4%) |
| Jun 1995 | - | $6.90 M(+4.5%) |
| Mar 1995 | - | $6.60 M(+3.1%) |
| Dec 1994 | $6.40 M(+6.7%) | $6.40 M(+1.6%) |
| Sep 1994 | - | $6.30 M(+5.0%) |
| Jun 1994 | - | $6.00 M(+9.1%) |
| Mar 1994 | - | $5.50 M(-8.3%) |
| Dec 1993 | $6.00 M(+17.6%) | $6.00 M(+1.7%) |
| Sep 1993 | - | $5.90 M(0.0%) |
| Jun 1993 | - | $5.90 M(+11.3%) |
| Mar 1993 | - | $5.30 M(+3.9%) |
| Dec 1992 | $5.10 M(+54.5%) | $5.10 M(+2.0%) |
| Sep 1992 | - | $5.00 M(+13.6%) |
| Jun 1992 | - | $4.40 M(+22.2%) |
| Mar 1992 | - | $3.60 M(+9.1%) |
| Dec 1991 | $3.30 M(+3.1%) | $3.30 M(-5.7%) |
| Sep 1991 | - | $3.50 M(0.0%) |
| Jun 1991 | - | $3.50 M(>+9900.0%) |
| Mar 1991 | - | $0.00(-100.0%) |
| Dec 1990 | $3.20 M | $3.20 M(>+9900.0%) |
| Sep 1990 | - | $0.00(0.0%) |
| Jun 1990 | - | $0.00(0.0%) |
| Mar 1990 | - | $0.00 |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual total debt?
- What is the all time high annual total debt for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual total debt year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly total debt?
- What is the all time high quarterly total debt for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly total debt year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual total debt?
The current annual total debt of VRTX is $1.75 B
What is the all time high annual total debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual total debt is $1.75 B
What is Vertex Pharmaceuticals Incorporated annual total debt year-on-year change?
Over the past year, VRTX annual total debt has changed by +$941.10 M (+116.42%)
What is Vertex Pharmaceuticals Incorporated quarterly total debt?
The current quarterly total debt of VRTX is $1.75 B
What is the all time high quarterly total debt for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly total debt is $1.75 B
What is Vertex Pharmaceuticals Incorporated quarterly total debt year-on-year change?
Over the past year, VRTX quarterly total debt has changed by +$941.10 M (+116.42%)